STAT5A and ductal breast carcinoma in situ: Together our results indicate a possible implication of STAT5a in estrogen-stimulated DCIS progression, a phenomenon that could be initiated by a decrease in stromal Cav-1 in vivo, and this possibility will also be tested in future studies with co-cultures with cancer fibroblasts.